Dialysis provider DaVita Inc. (NYSE:DVA) in Q3 CY2025, with sales up 4.8% year on year to $3.42 billion. Its non-GAAP profit of $2.51 per share was 20.9% below analysts’ consensus estimates. Is now the time to buy DaVita?

DaVita missed Wall Street estimates for third-quarter profit on Wednesday, as the kidney dialysis provider grappled with rising patient care costs and declining treatment volumes.

Investing.com-- DaVita HealthCare Partners (NYSE:DVA) shares fell in aftermarket trade on Wednesday after the dialysis machine maker clocked disappointing third-quarter earnings, while Berkshire Hathaway (NYSE:BRKa) further trimmed its stake in the firm. Davita shares fell as much as 3% afterhours to $122.70.

That's the situation with the following three undervalued healthcare stocks. So far this year, shares in dialysis center operator DaVita ( DVA +0.91%) have slumped, falling by around 14% since January. A variety of factors have put pressure on the stock.

Thank you, and welcome to our third quarter conference call. Please note that during this call, we may make forward-looking statements within the meaning of the federal securities laws. All of these statements are subject to known and unknown risks and uncertainties,

DaVita HealthCare Partners contacted Medicaid-eligible dialysis patients with private insurance enrollment information. The organization says the information was meant to educate patients, while a report from the St. Louis Post-Dispatch raised questions ...

DaVita Inc. the nation’s largest operator of dialysis clinics, on Monday said it would buy HealthCare Partners, Los Angeles County’s largest operator of physician practices, in a deal valued at more than $4.4 billion. The purchase price includes of $3. ...

DENVER (AP) -- Kidney dialysis services provider DaVita Inc. said Monday that it has agreed to buy the doctor network operator HealthCare Partners in a cash-stock deal worth about $4.42 billion. Denver-based DaVita said it will pay about $3.66 billion in ...

DaVita Healthcare in Denver will acquire Renal Ventures, a privately-held dialysis care company, for $415 million. 1. With this acquisition, DaVita plans to expand its kidney care. 2. DaVita comprises about 2,200 clinics across 46 states and 10 countries.